Cargando…
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis
Background: In the human central nervous system (CN), resting astrocytes do not visually show endothelin-1 (ET-1)-like immunoreactivity. In patients with multiple sclerosis (MS), an inflammatory disorder of the CNS, high levels of ET-1 are found in reactive astrocytes in demyelinated plaques. ET-1 m...
Autores principales: | Hostenbach, Stéphanie, D’Haeseleer, Miguel, Kooijman, Ron, De Keyser, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960227/ https://www.ncbi.nlm.nih.gov/pubmed/31969819 http://dx.doi.org/10.3389/fphar.2019.01491 |
Ejemplares similares
-
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results
por: Hostenbach, Stéphanie, et al.
Publicado: (2020) -
Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan
por: Hostenbach, Stéphanie, et al.
Publicado: (2019) -
Definition, prevalence and predictive factors of benign multiple sclerosis
por: Reynders, Tatjana, et al.
Publicado: (2017) -
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020) -
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)